Medical vs. Recreational Cannabis: Where Should I Invest?
Increasing your exposure to a variety of companies gives you the best chance to profit.
Increasing your exposure to a variety of companies gives you the best chance to profit.
In 2018, 4/20 marked the beginning of a blazing run for a number of cannabis companies.
Canopy Growth has secured the right to snatch up the largest MSO in the U.S. for a whopping $3.4 billion.
As each 4/20 comes and goes, the outlook for the cannabis sector gets brighter – not hazier. This year is one to celebrate.
Even though there’s been a steep pullback in shares, is the cannabis sector still overvalued?
Shares are their most volatile during earnings season, so it’s a great time to go bargain hunting or to book big gains.
Martha Stewart signed on as an advisor for Canopy Growth to create a line of CBD products for animals.
My team and I looked at cannabis companies’ revenue growth from last quarter… and the numbers are eye-popping.
Investors who embrace fundamentals and pay attention to valuations will eventually win.
Matthew shares which stocks are overpriced and which are ripe for the taking.